We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Medical Properties Trust Buys 40 Hospitals in Germany

By HospiMedica International staff writers
Posted on 05 Nov 2014
Medical Properties Trust (MPT; Birmingham, AL, USA) has signed a sale and leaseback agreement with Median Kliniken Group (Median; Berlin, Germany), the largest provider of post-acute and acute rehabilitation services in Germany.

Under the terms of the agreement, an affiliate of Waterland Private Equity (Waterland; Bussum, The Netherlands) will acquire a 94.9% equity interest in Median. More...
MPT will acquire the remaining 5.1% stake and will provide loans for up to the USD 900 million purchase price of the sale/leaseback real estate. The deal includes 38 rehabilitation and two acute care hospitals all over Germany. The agreement is also pursuant to a 27 year master lease with an initial lease rate within MPT’s 8%–11% target range, with annual escalators at the greater of 1% or 70% of the German consumer price index (CPI).

In addition to the Median acquisition, MPT also announced approximately USD 155 million in commitments and investments, including three acute facilities in the United States and three additional German rehabilitation hospitals to be leased to RHM Kliniken (Deidesheim, Germany), a current tenant of assets in Germany owned by affiliates of Waterland, the expected future majority owner of Median. The new facilities will also be leased back under long-term net leases with a weighted average initial cash lease rate of approximately 9.3% and CPI-based escalators.

“The acquisition of the Median real estate is a very compelling and unique opportunity for MPT and is fully aligned with our strategy to diversify our market-leading hospital portfolio across geography, operator, and facility type,” said Edward K. Aldag, Jr., CEO of Medical Properties Trust. “This is an important transaction because it significantly increases our asset base…and builds on our recent entry into the attractive Western European market.”

The transactions will significantly expand MPT’s asset base by approximately 30% to USD 4.5 billion, grow the total number of properties in its portfolio to 165, and increase the number of hospital beds by approximately 98%, to nearly 20,000 beds.

“As we increase our exposure to the positive European market dynamics, we will also maintain our core investment focus on the United States,” concluded Mr.Aldag. “We will continue to extend our leadership in the US market and build upon our new track record in Western Europe by selectively pursuing the most attractive opportunities with the goal of leveraging our strong investment capabilities for the benefit of our shareholders.”

Related Links:

Medical Properties Trust
Median Kliniken Group
Waterland Private Equity




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.